Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
Did you know that India has a neighbouring country whose shape looks just like a…
Did you know glass is not just something we use every day — it is…
India’s agricultural exports to the United States are expected to witness a strong boost, with…
In a major boost to India’s air power, the Defence Acquisition Council (DAC), chaired by…
India’s retail inflation stood at 2.75 percent in January 2026 under the new Consumer Price…
Did you know that some crops are not only food but also the backbone of…